By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Gulf PressGulf Press
  • Home
  • Gulf News
    • Saudi Arabia
    • UAE24/7
    • Kuwait
    • Qatar
    • Bahrain
    • Oman
  • World
  • Business
    • Market DataLive
    • Finance
    • Economy
    • Energy
    • Crypto
    • ForexHot
    • Tech
  • Sports
  • Lifestyle
  • Videos
Search
Countries
  • Saudi Arabia
  • UAE
  • Kuwait
  • Qatar
  • Bahrain
  • Oman
More Topics
  • Technology
  • Health
  • Entertainment
  • Crypto
  • Forex
  • Stocks
Site Links
  • Business Hub
  • Trending
  • Weather
  • Customize Interests
  • Bookmarks
  • Newsletter
  • Terms
  • Press Release
  • Advertise
  • Contact
© 2023 Gulf Press. All Rights Reserved.
Reading: Symptoms may be reduced with slow-release ketamine tablet for at-home use
Share
Notification Show More
Recent Saved
Workers in Bucharest face challenges as temperatures rise
World
Dress code guidelines for the Qatari government sector during office hours
Qatar
Court rules in favor of worker after company dismisses him for salary deductions over 6 years, awarding BD 27,000.
Bahrain
UAE to See Almost 30,000 New Millionaires in 5 Years
UAE
Proposed New Labor Law in Bahrain Targets Increasing Job Opportunities
Bahrain
Latest News
UAE Ranks Among Top Rugby Markets on TOD as British & Irish Lions Tour Kicks Off
Sports
Darven: A New Leap in AI-Powered Legal Technology Launching from the UAE to the World
Tech
Beat the Heat This Summer with a Chill Out on Dubai Marina
World
Historic Italian City of Assisi to Host International Exhibition “Jordan: Dawn of Christianity”
World
Jordan to Host Iraq in the Final Round of the Asian World Cup Qualifiers After Securing Historic Spot
Sports
The Myriad Redefines Student Living for a Mobile, Urban Generation
UAE
L’Oréal Paris Welcomes Yasmine Sabri as New Brand Ambassador for the Middle East
Lifestyle
Roland Garros 2025: A New Era of Viewing, A Tribute to Legends, and Moments to Remember
Sports World
Bitget Celebrates Bitcoin Pizza Day by Distributing Over 5000 Pizzas in Over 20 Cities Worldwide
Crypto
Bitget Protection Fund Maintains Strength with $561 Million Average Value in April 2025
Business Crypto
Aa
Gulf PressGulf Press
Aa
  • Gulf News
  • World
  • Business
  • Entertainment
  • Lifestyle
  • Sports
  • Videos
Search
  • Home
    • Videos
    • Business Hub
    • Trending
  • Gulf
    • Saudi Arabia
    • UAE
    • Kuwait
    • Qatar
    • Bahrain
    • Oman
  • Business
    • Market Data
    • Crypto
    • Economy
    • Energy
    • Finance
    • Forex
    • Tech
  • More News
    • World
    • Lifestyle
    • Entertainment
    • Sports
Have an existing account? Sign In
Follow US
  • Terms
  • Press Release
  • Advertise
  • Contact
© 2023 Gulf Press. All Rights Reserved.
Gulf Press > Health > Symptoms may be reduced with slow-release ketamine tablet for at-home use
Health

Symptoms may be reduced with slow-release ketamine tablet for at-home use

News Room
Last updated: 2024/07/05 at 11:09 PM
News Room
Share
3 Min Read
SHARE

Ketamine has shown promise in treating treatment-resistant depression, but the current form of the medication requires clinical supervision, making it expensive. A recent early-stage study tested an experimental slow-release ketamine capsule that can be taken at home, which could potentially reduce costs if it makes it to market. The current form of ketamine treatment involves a nasal spray or injection, which requires patients to stay in the clinic for monitoring for around 2 hours. The FDA currently only approves ketamine for short-term sedation and anesthesia.

Injected ketamine has been shown to be more effective than the nasal version, esketamine, and larger doses are most effective. Ketamine starts working within hours, unlike traditional antidepressants that may take weeks to show results. Ketamine can provide rapid relief for individuals with severe depression, which can be life-saving. However, ketamine also has potential side effects and abuse potential, making the development of a safer form of the drug crucial.

The recent BEDROC study tested an experimental slow-release ketamine capsule designed by Douglas Pharmaceuticals in New Zealand, called R-107, which slowly releases ketamine over 24 hours. Participants with treatment-resistant depression were split into groups receiving varying doses of R-107 or a placebo. The study found improvements in depression symptoms in the groups taking R-107 compared to the placebo group. The treatment was well-tolerated, with common side effects such as dizziness, headache, and nausea reported by participants.

Ketamine acts as an NMDA receptor antagonist in the brain, leading to a cascade of neurochemical events that promote synaptic plasticity and alleviate depressive symptoms. The drug may also affect the brain’s default mode network and reduce inflammation, further reducing symptoms. While the results of the recent study are promising, further research is needed to replicate the findings in larger, longer trials globally. Douglas Pharmaceuticals plans to conduct Phase 3 studies to determine the effectiveness of R-107 before it can become widely available as a treatment for treatment-resistant depression.

In conclusion, the development of a slow-release oral version of ketamine could potentially reduce costs and make the treatment more accessible for individuals with treatment-resistant depression. The recent study showed promising results in improving depression symptoms with minimal side effects compared to traditional forms of ketamine. Further research and larger trials are necessary before the drug can be widely available, but the potential benefits of a safer and more cost-effective form of ketamine for depression treatment are significant.

Sign Up For Daily Newsletter

Be keep up! Get the latest breaking news delivered straight to your inbox.
I have read and agree to the terms & conditions
By signing up, you agree to our Terms of Use and acknowledge the data practices in our Privacy Policy. You may unsubscribe at any time.
News Room July 5, 2024
Share this Article
Facebook Twitter Copy Link Print
Previous Article Australian intelligence agency transfers intelligence information to Amazon cloud in new deal
Next Article France defeats Portugal in penalties to advance to Euro 2024 semi-finals.
Leave a comment Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Stay Connected

235.3k Followers Like
69.1k Followers Follow
56.4k Followers Follow
136k Subscribers Subscribe
- Advertisement -
Ad imageAd image

Latest News

UAE Ranks Among Top Rugby Markets on TOD as British & Irish Lions Tour Kicks Off
Sports July 6, 2025
Darven: A New Leap in AI-Powered Legal Technology Launching from the UAE to the World
Tech July 1, 2025
Beat the Heat This Summer with a Chill Out on Dubai Marina
World July 1, 2025
Historic Italian City of Assisi to Host International Exhibition “Jordan: Dawn of Christianity”
World June 28, 2025

You Might also Like

Health

Mindfulness could be equally effective as antidepressants

October 17, 2024
Health

What is the impact of caffeine on the risk of developing diseases?

October 17, 2024
Health

Scientists discover combination of 14 genes that enhance outcomes

October 16, 2024
Health

Seizure medication demonstrates potential in individuals with no genetic risk

October 16, 2024
Health

Heart disease increases risk, heparin can postpone onset

October 16, 2024
Health

What type of breakfast is most effective for weight loss in women compared to men?

October 15, 2024
Health

How does the brain remove “waste” to protect itself?

October 14, 2024
Health

How does stress, sleep, and gut imbalances affect it?

October 13, 2024
//

Gulf Press is your one-stop website for the latest news and updates about Arabian Gulf and the world, follow us now to get the news that matters to you.

Quick Link

  • Privacy Policy
  • Terms of ue
  • Advertise
  • Contact

How Topics

  • Gulf News
  • International
  • Business
  • Lifestyle

Sign Up for Our Newsletter

Subscribe to our newsletter to get our latest news instantly!

I have read and agree to the terms & conditions
Gulf PressGulf Press
Follow US

© 2023 Gulf Press. All Rights Reserved.

Join Us!

Subscribe to our newsletter and never miss our latest news, podcasts etc..

I have read and agree to the terms & conditions
Zero spam, Unsubscribe at any time.

Removed from reading list

Undo
Welcome Back!

Sign in to your account

Lost your password?